![]() |
|
|
Forward to a colleague |
||
Access Full Stories GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read Singapore's pharma output continues to slow Singapore's biomedical manufacturing output was down again over October, stunting growth for the region's entire manufacturing sector... Read PolyTherics gets funding for antibody fragments PolyTherics has been boosted with £350,000 ($723,135) in funding to explore the development and production of long-lasting therapeutic antibody fragments... Read Pharma should keep outsourcing in mind The pharmaceutical industry is backward when it comes to outsourcing, industry experts said at the American Association of Pharmaceutical Scientists (AAPS) conference in San Diego last week... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read |
|||||||||||||
All News Headlines for: November | October | September |
|||||||||||||
![]() Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here | |||||||||||||
|
Related Industry News AstraZeneca finds buyer for German plant Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility... Read Xenome and Amylin team up to poison metabolic diseases Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read Astellas snaps up cancer antibody specialists Agensys Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer... Read Chromatide wins GRAND grant for enzyme-catalysis development Chromatide has been awarded a grant to help it develop an enzyme immobilisation method using its unique polymer systems that should enable them to be used in flow-chemistry systems... Read
|
|||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||